Brief: Avenue Therapeutics Inc Says Co Received An Acknowledgement Letter From Office Of New Drugs Of Food And Drug Administration
21/09/2021 13:52
Sept 21 (Reuters) - Avenue Therapeutics Inc ATXI.O :
* AVENUE THERAPEUTICS INC - ON SEPTEMBER 17, RECEIVED AN
ACKNOWLEDGEMENT LETTER FROM OFFICE OF NEW DRUGS OF FOOD AND DRUG
ADMINISTRATION
* AVENUE THERAPEUTICS INC - LETTER STATED THAT A RESPONSE
WILL BE
PROVIDED BY OCTOBER 28, 2021
* AVENUE THERAPEUTICS - ACKNOWLEDGEMENT LETTER WAS REGARDING
AVENUE'S FDRR CONCERNING COMPLETE RESPONSE LETTERS ISSUED FOR
NDA FOR INTRAVENOUS TRAMADOL
Source text for Eikon: [https://bit.ly/3hT19Z1]
Further company coverage: ATXI.O
Recent news on Avenue Therapeutics
See all newsBrief: Axsome Therapeutics Acquires AZD7325, A Selective GABA-A Modulator For Treatment Of Epilepsy
Avenue Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Avenue Therapeutics Annji Intends To Terminate License Agreement With Co
Brief: Avenue Therapeutics Receives Delist Letter From Nasdaq Under Nasdaq Listing Rule 5550(B)(1)
Avenue Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary